WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
WuXi PharmaTech (WX) Tops Q4 EPS by 2c, FY Guidance Falls Short
March 5, 2015 4:41 PM ESTWuXi PharmaTech (NYSE: WX) reported Q4 EPS of $0.55, $0.02 better than the analyst estimate of $0.53. Revenue for the quarter came in at $190.6 million versus the consensus estimate of $189.54 million.
WuXi PharmaTech sees FY2015 EPS of $1.73-$1.75, versus the consensus of $2.10. WuXi PharmaTech sees FY2015... More
